Fibroblast growth factor 23 as a biomarker of right ventricular dysfunction in pulmonary hypertension.

Clinical research in cardiology : official journal of the German Cardiac Society(2023)

引用 0|浏览33
暂无评分
摘要
FGF-23 may serve as a biomarker for maladaptive RV remodeling in patients with PH.
更多
查看译文
关键词
CTEPH,DCM,Fibrosis,IPAH,LV hypertrophy,RV-PA coupling
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要